Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Major Tom who wrote (4203)	9/23/1998 11:36:00 AM
From: UnderCover	Read Replies (1) \| Respond to of 5402

Talk around the campfire is that AHN went extremely well, but that CNNFN wasn't as good as expected. I don't know. I didn't see either one, so I have no opinion as to content or possible effects. I assume that Dr. Drees did exactly what he thought was necessary. The man has a Ph.D. in economics; that's reason enough for me to believe. Who knows, maybe the edit process from CNNFN soured his intentions, or maybe the good Dr. accomplished exactly what he set out to do. We have already seen that the major pharmaceutical companies are ready, willing, and able to spend what ever it takes to get synthetic blood on the market. I certainly can't say this for sure, but maybe what he had in mind was a buy out by a major and to let the majors know we could use some help. Time will tell. I think that the man is a genius and more than likely he turned up just the cards he wanted to show.